TIMMDC1 — Translocase of Inner Mitochondrial Membrane Domain Containing 1

TIMMDC1 — Translocase of Inner Mitochondrial Membrane Domain Containing 1

Overview

TIMMDC1 — Translocase of Inner Mitochondrial Membrane Domain Containing 1

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">TIMMDC1 — Translocase of Inner Mitochondrial Membrane Domain Containing 1</th>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Skeletal Muscle</td>
<td>High</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>High</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">AMPK</td>
<td>Activated by low ATP</td>
</tr>
<tr>
<td class="label">mTOR</td>
<td>Often inhibited</td>
</tr>
<tr>
<td class="label">SIRT1</td>
<td>Dysregulated</td>
</tr>
<tr>
<td class="label">NRF2</td>
<td>Altered antioxidant response</td>
</tr>
<tr>
<td class="label">PGC-1alpha</td>
<td>Reduced expression</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>

TIMMDC1 (Translocase of Inner Mitochondrial Membrane Domain Containing 1) is a critical mitochondrial assembly factor essential for the proper formation and stabilization of respiratory Complex I (NADH:ubiquinone oxidoreductase). Encoded by the TIMMDC1 gene (ENSG00000109684) located on chromosome 3q21.3, this protein plays a vital role in the oxidative phosphorylation (OXPHOS) system, particularly in tissues with high energy demands such as the brain, heart, and skeletal muscle.

Complex I deficiency is one of the most common respiratory chain disorders, accounting for approximately 30% of all mitochondrial disease cases [1](https://pubmed.ncbi.nlm.nih.gov/20084066/). TIMMDC1 mutations represent a relatively recently discovered cause of isolated complex I deficiency, with clinical manifestations ranging from severe encephalomyopathy to milder metabolic phenotypes.

Molecular Biology and Structure

Gene Organization

The TIMMDC1 gene spans approximately 15 kb of genomic DNA and comprises 12 exons encoding a protein of 299 amino acids. The protein is localized to the mitochondrial inner membrane, where it functions as a non-catalytic assembly factor. TIMMDC1 belongs to the mitochondrial carrier protein family but lacks transport activity, instead serving a structural role in complex I biogenesis [2](https://doi.org/10.1016/j.bbabio.2011.01.009).

Protein Domains and Topology

TIMMDC1 contains multiple transmembrane helices that anchor it to the mitochondrial inner membrane. The protein interacts specifically with the Q module (ubiquinone-binding module) of complex I, facilitating the correct assembly of this crucial structural domain. The N-terminal domain extends into the mitochondrial matrix, while the C-terminal portion interacts with other assembly factors including NDUFAF2 (B17.2L) and NDUFAF3 [3](https://pubmed.ncbi.nlm.nih.gov/21278787/).

Complex I Assembly Pathway

Mitochondrial complex I (NADH:ubiquinone oxidoreductase) is the largest enzyme of the electron transport chain, comprising 44 core subunits and over 30 assembly factors. TIMMDC1 participates in a well-characterized assembly pathway:

The assembly process involves a coordinated cascade of chaperone proteins including COA7, DAP3, and the MITOX complex [4](https://pubmed.ncbi.nlm.nih.gov/25604759/).

Function in Cellular Physiology

Oxidative Phosphorylation

TIMMDC1 is essential for maintaining the integrity of the mitochondrial respiratory chain. Complex I is the entry point for electrons from NADH, transferring them to coenzyme Q (ubiquinone) and subsequently to complex III. This process drives proton pumping across the inner mitochondrial membrane, creating the electrochemical gradient (ΔΨm) that powers ATP synthesis [5](https://pubmed.ncbi.nlm.nih.gov/19815864/).

The functional consequences of TIMMDC1 deficiency include:

• Reduced NADH:ubiquinone oxidoreductase activity
• Impaired ATP production via oxidative phosphorylation
• Disrupted mitochondrial membrane potential
• Altered NAD+/NADH ratio affecting cellular metabolism

Reactive Oxygen Species Management

Proper complex I function is crucial for managing reactive oxygen species (ROS) production. Electron leak from complex I is a primary source of mitochondrial superoxide (O₂⁻). While low levels of ROS serve as signaling molecules, excessive production leads to oxidative stress—a key contributor to neurodegeneration [6](https://pubmed.ncbi.nlm.nih.gov/19568742/).

TIMMDC1 deficiency can lead to:

• Increased basal ROS production
• Dysregulated antioxidant responses
• Oxidative damage to proteins, lipids, and DNA
• Activation of stress-sensitive signaling pathways

Neuronal Energy Metabolism

[Neurons](/entities/neurons) have exceptionally high energy requirements for maintaining membrane potentials, neurotransmission, and axonal transport. Mitochondria are dynamically distributed to regions of high energy demand, and complex I dysfunction disproportionately affects neuronal function [7](https://pubmed.ncbi.nlm.nih.gov/19428808/).

TIMMDC1 and proper complex I function are crucial for:

• ATP production: ~36 ATP molecules per glucose molecule through OXPHOS
• Calcium homeostasis: Mitochondrial calcium uptake and buffering
• Axonal transport: Mitochondrial dynamics and distribution along axons
• Synaptic function: Energy-intensive neurotransmitter release and recycling

Disease Associations

Mitochondrial Complex I Deficiency

TIMMDC1 mutations cause isolated complex I deficiency, one of the most common mitochondrial disorders with an estimated prevalence of 1:35,000 live births. The clinical phenotype varies widely based on the specific mutation and residual complex I activity [8](https://pubmed.ncbi.nlm.nih.gov/20084066/).

Core clinical features include:

• Encephalomyopathy: Combined brain and muscle involvement
• Developmental delay: Cognitive and motor delays in childhood
• Seizures: Epileptic activity, often refractory to treatment
• Hypotonia: Generalized low muscle tone
• Cardiomyopathy: Hypertrophic or dilated cardiomyopathy
• Lactic acidosis: Elevated blood and CSF lactate levels
• Failure to thrive: Growth retardation in infancy

Leigh Syndrome

Complex I deficiency often presents as Leigh syndrome (subacute necrotizing encephalomyelopathy), a devastating neurodegenerative disorder characterized by:

• Bilateral basal ganglia lesions on MRI
• Progressive loss of motor and cognitive skills
• Episodic regression during illness
• Median survival of 2-4 years

MELAS/MEA Overlap

Some TIMMDC1 variants cause mitochondrial encephalomyopathy with lactic acidosis (MELAS)-like phenotypes, featuring:

• Stroke-like episodes in childhood
• Migraine-type headaches
• Sensorineural hearing loss
• Diabetes mellitus
• Ragged-red fibers on muscle biopsy

Parkinson's Disease

Complex I dysfunction is strongly implicated in Parkinson's disease (PD) pathogenesis. The selective vulnerability of dopaminergic neurons in the substantia nigra to complex I impairment has been extensively documented [10](https://pubmed.ncbi.nlm.nih.govPMC2711524/).

Multiple lines of evidence link TIMMDC1 to PD:

• Genetic association: TIMMDC1 variants have been identified in PD patients
• Complex I defects: Post-mortem PD brains show reduced complex I activity
• Environmental toxins: Complex I inhibitors (MPTP, rotenone) induce parkinsonism
• Mitochondrial dynamics: PD-related genes (PINK1, PARKIN) regulate mitochondrial quality
• α-synuclein aggregation: Mitochondrial dysfunction promotes aggregation

• Oxidative stress promotion
• Impaired autophagy-lysosomal degradation
• Endoplasmic reticulum-mitochondria dysfunction
• Elevated ROS-driven protein misfolding [11](https://pubmed.ncbi.nlm.nih.gov/29187149/)

Expression Pattern

Tissue Distribution

TIMMDC1 is expressed ubiquitously but shows highest expression in tissues with high oxidative metabolic demand:

Brain Regional Expression

Within the brain, TIMMDC1 shows particular enrichment in:

• Cerebral cortex: Higher cortical functions
• Basal ganglia: Motor control, dopaminergic neurons
• Cerebellum: Motor coordination
• Hippocampus: Learning and memory
• Substantia nigra: Dopaminergic neuron survival

Cellular Localization

In neurons, TIMMDC1 is distributed throughout the soma, dendrites, and axons, with particular concentration at:

• Synaptic terminals (pre- and post-synaptic)
• Axonal initial segments
• Nodes of Ranvier
• Growth cones during development

Therapeutic Implications

Current Treatment Strategies

Currently, treatment for complex I deficiency is largely supportive:

• Coenzyme Q10 (CoQ10): May partially bypass complex I defects by providing alternative electron entry
• L-carnitine: Supports fatty acid oxidation and mitochondrial function
• Vitamin supplements: B-complex, vitamin C, vitamin E
• Seizure management: Anticonvulsant medications
• Physical therapy: Maintain motor function
• Dietary management: Ketogenic diet may provide alternative fuel

Emerging Therapeutic Approaches

Precision Medicine

Understanding the specific TIMMDC1 mutation allows for personalized treatment:

• Nonsense mutations: Readthrough compounds (ataluren)
• Splicing defects: Antisense oligonucleotides
• Misfolding: Pharmacological chaperones

Interactions and Pathways

Protein-Protein Interactions

TIMMDC1 interacts with multiple components of the complex I assembly machinery:

• NDUFAF2 (B17.2L): Assembly factor for Q module
• NDUFAF3: Early assembly factor
• NDUFAF5/SARAF: Sulfhydration-related assembly
• ND1 subunit (MT-ND1): Core subunit of complex I
• ND2 subunit (MT-ND2): Membrane arm subunit

Signaling Pathways

TIMMDC1 dysfunction affects multiple cellular signaling pathways:

Cross-Links

• [Mitochondrial Complex I](/mechanisms/mitochondrial-complex-i)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress-neurodegeneration)
• [Mitochondrial DNA Depletion Syndrome](/diseases/mitochondrial-dna-depletion-syndrome)
• [Leigh Syndrome](/diseases/leigh-syndrome)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [PINK1](/genes/pink1)
• [PARKIN](/genes/parkin)
• [Complex I Assembly Factors](/mechanisms/complex-i-assembly)

See Also

• [Mitochondrial Complex I](/mechanisms/mitochondrial-complex-i)
• [Oxidative Phosphorylation](/mechanisms/oxidative-stress-neurodegeneration)
• [Mitochondrial DNA Depletion Syndrome](/diseases/mitochondrial-dna-depletion-syndrome)
• [Leigh Syndrome](/diseases/leigh-syndrome)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)

External Links

• [Ensembl: ENSG00000109684](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000109684)
• [UCSC Genome Browser: TIMMDC1](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&position=chr3%3A126927764-126943102)
• [GeneCards: TIMMDC1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIMMDC1)
• [OMIM: TIMMDC1](https://www.omim.org/entry/615214)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TIMMDC1 — Translocase of Inner Mitochondrial Membrane Domain Containing 1 discovered through SciDEX knowledge graph analysis: